These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3406234)

  • 1. Influence of the cholinergic agonist RS 86 on normal sleep: sex and age effects.
    Riemann D; Joy D; Höchli D; Lauer C; Zulley J; Berger M
    Psychiatry Res; 1988 May; 24(2):137-47. PubMed ID: 3406234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep, age, depression and the cholinergic REM induction test with RS 86.
    Riemann D; Berger M
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 May; 16(3):311-6. PubMed ID: 1589588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the cholinergic agonist SDZ 210-086 on sleep in healthy subjects.
    Hohagen F; Riemann D; Spiegel R; Holzhauer M; Berger M
    Neuropsychopharmacology; 1993 Nov; 9(3):225-32. PubMed ID: 8280346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.
    Riemann D; Hohagen F; Bahro M; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(5):279-90. PubMed ID: 8172943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholinergic and noradrenergic neurotransmission: impact on REM sleep regulation in healthy subjects and depressed patients.
    Riemann D; Hohagen F; Fritsch-Montero R; Krieger S; Gann H; Dressing H; Muller W; Berger M
    Acta Psychiatr Belg; 1992; 92(3):151-71. PubMed ID: 1345430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG sleep in depression and in remission and the REM sleep response to the cholinergic agonist RS 86.
    Riemann D; Berger M
    Neuropsychopharmacology; 1989 Jun; 2(2):145-52. PubMed ID: 2742728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholinergic REM induction test with RS 86 after scopolamine pretreatment in healthy subjects.
    Riemann D; Hohagen F; Fleckenstein P; Schredl M; Berger M
    Psychiatry Res; 1991 Sep; 38(3):247-60. PubMed ID: 1754637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sleep structure of patients with anxiety disorders in comparison to that of healthy controls and depressive patients under baseline conditions and after cholinergic stimulation.
    Gann H; Riemann D; Hohagen F; Dressing H; Müller WE; Berger M
    J Affect Disord; 1992 Nov; 26(3):179-89. PubMed ID: 1460168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders.
    Schreiber W; Lauer CJ; Krumrey K; Holsboer F; Krieg JC
    Biol Psychiatry; 1992 Jul; 32(1):79-90. PubMed ID: 1391297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
    Berger M; Riemann D; Höchli D; Spiegel R
    Arch Gen Psychiatry; 1989 May; 46(5):421-8. PubMed ID: 2712660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic neurotransmission, REM sleep and depression.
    Riemann D; Hohagen F; Bahro M; Lis S; Stadmüller G; Gann H; Berger M
    J Psychosom Res; 1994; 38 Suppl 1():15-25. PubMed ID: 7799246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of RS 86, an orally active cholinergic agonist, on sleep in man.
    Spiegel R
    Psychiatry Res; 1984 Jan; 11(1):1-13. PubMed ID: 6369363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the muscarinic M1 receptor agonist RS-86 and the acetylcholine-esterase inhibitor donepezil on REM sleep regulation in healthy volunteers.
    Nissen C; Nofzinger EA; Feige B; Waldheim B; Radosa MP; Riemann D; Berger M
    Neuropsychopharmacology; 2006 Jun; 31(6):1294-300. PubMed ID: 16192980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives.
    Krieg JC; Berger M
    Acta Psychiatr Scand; 1987 Nov; 76(5):600-2. PubMed ID: 3434333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of RS 86 on REM latency in schizophrenia.
    Riemann D; Gann H; Fleckenstein P; Hohagen F; Olbrich R; Berger M
    Psychiatry Res; 1991 Jul; 38(1):89-92. PubMed ID: 1946836
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86.
    Lauer CJ; Modell S; Schreiber W; Krieg JC; Holsboer F
    J Clin Psychopharmacol; 2004 Jun; 24(3):356-7. PubMed ID: 15118498
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholinomimetic drug RS 86, REM sleep, and depression.
    Berger M; Höchli D; Zulley J; Lauer C; von Zerssen D
    Lancet; 1985 Jun; 1(8442):1385-6. PubMed ID: 2861327
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sleep in anorexia nervosa, bulimia nervosa and depressive diseases: a polysomnographic comparative study].
    Lauer C; Krieg JC; Zulley J; Riemann D; Berger M
    Fortschr Neurol Psychiatr; 1989 Oct; 57(10):403-10. PubMed ID: 2680843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic drugs as diagnostic and therapeutic tools in affective disorders.
    Berger M; Riemann D; Krieg C
    Acta Psychiatr Scand Suppl; 1991; 366():52-60. PubMed ID: 1897376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep.
    Foster NL; Aldrich MS; Bluemlein L; White RF; Berent S
    Neurology; 1989 Feb; 39(2 Pt 1):257-61. PubMed ID: 2644580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.